BeBetter Med logo

BeBetter Med

Clinical-stage drug discovery and development of advanced novel medicines for cancer and other severe illnesses.

5 employees · est. 2012 · China

VS
RemeGen荣昌生物 logo

RemeGen荣昌生物

用科学提高生命质量

35 employees · est. 2008 · Yantai, China

RemeGen荣昌生物 is the older company (2012 vs 2008); RemeGen荣昌生物 is the larger of the two.

Side-by-Side Comparison

BeBetter Med RemeGen荣昌生物
Founded
2012 2008 older
Headquarters
China Yantai, China
Employees
5 35 larger
Industry
Health Care, Pharmaceutical Not tracked yet
Funding Stage
Private Equity Post IPO
Total Funding
$499.00M $1.03B
Funding Rounds
2 3
Services
Not tracked yet Drug Discovery, Research and Development, Biological Medicine Manufacturing, Clinical Trial Conducting, New Drug Market Launch
Target Customers
Not tracked yet Patients with Major Diseases, Healthcare Providers, Medical Institutions, Pharmaceutical Distributors
Taxonomy
Drug Discovery, Clinical-stage, Novel Medicines, Cancer Treatment, Pharmaceutical Research, Oncology Drugs, Metabolic Disease, Clinical Development, Small Molecule Drugs, Clinical Trials, IP Rights, Guangzhou, Biopharmaceutical Company, Overseas Returnees Biologics, Biotech Innovation, Therapeutic Innovation, Cancer Treatment, Autoimmune Disease Therapy, Eye Disease Treatment, Biopharmaceutical Industry, ADC (Antibody-Drug Conjugates), Biological Drugs, Clinical Studies, Drug Development, Unmet Clinical Needs, Global Commercialization, Scientific Research Investment, Differentiated Drugs
Website
bebettermed.cn remegen.cn
BeBetter Med logo

About BeBetter Med

BeBetter Med is a rapidly growing novel drug discovery and development company based in Guangzhou, China. Founded in 2012 by overseas returnees, the company is dedicated to creating advanced novel medicines for the treatment of cancer and other severe diseases. With a focus on clinical-stage drug di...

RemeGen荣昌生物 logo

About RemeGen荣昌生物

RemeGen荣昌生物 is positioning itself as a trailblazer in the biotech industry with its innovative approach to biologic medicines. Founded in 2008, this Chinese biotech firm is focused on transforming the treatment landscape for cancer, autoimmune, and eye diseases by pioneering biologics. With a mi...

We will tell you when either one moves

BounceWatch watches BeBetter Med and RemeGen荣昌生物 for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BeBetter Med and RemeGen荣昌生物 — by email.

Frequently Asked Questions

BeBetter Med — Clinical-stage drug discovery and development of advanced novel medicines for cancer and other severe illnesses.. RemeGen荣昌生物 — 用科学提高生命质量. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BeBetter Med has raised $499.00M while RemeGen荣昌生物 has raised $1.03B.
BeBetter Med and RemeGen荣昌生物 operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BeBetter Med with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BeBetter Med on 12 Sep 2024, and RemeGen荣昌生物 on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy